EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Advancements and challenges in CAR T cell therapy for pediatric brain tumors: A review

Yasmina Gaoual iD, Adam Mahyaoui, Lamyae Yachi, Mustapha Bouatia, Zineb Aliat, Younes Rahali

Journal of Oncology Pharmacy Practice · 2025

DOI: 10.1177/10781552251331609 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Oncology Pharmacy Practice, 2025. Verfasst von Yasmina Gaoual und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Pharmacy, Mohammed V University in Rabat, 10 170 Rabat, Morocco. Hauptthemen laut MEDLINE: Brain Neoplasms, Immunotherapy, Adoptive. Die Arbeit nennt 79 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chimeric Antigen Receptor (CAR) T cell therapy represents a groundbreaking advancement in immunotherapy, initially gaining FDA approval for treating hematological malignancies. This therapy has shown promising results in solid tumors, particularly in pediatric brain tumors, which are the leading cause of cancer-related death in children. CAR T cells are engineered to target specific antigens on tumor cells, thereby reducing off-target effects and increasing the cytotoxic impact on cancer cells. Over the years, CAR T cell technology has evolved through five generations, each enhancing the structure, functionality, and safety of these cells. Despite these advancements, the application of CAR T cells in solid tumors, especially within the central nervous system (CNS), faces significant challenges. These include the physical barrier posed by the blood-brain barrier (BBB), the immunosuppressive tumor microenvironment (TME), and the heterogeneity of tumor antigens. The review discusses several promising antigenic targets for CAR T cells in pediatric brain tumors, such as HER2, EphA2, IL-13Rα2, and Survivin, which have been explored in recent clinical trials. These trials have shown early promise in improving patient outcomes, though the risks of cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS) remain concerns. The future of CAR T cell therapy lies in overcoming these barriers through innovative approaches like “Armored CARs” or TRUCKs, designed to modulate the TME and improve CAR T cell efficacy in solid tumors. Additionally, combination therapies and safety switches in next-generation CAR T cells are being explored to enhance therapeutic potential while minimizing adverse effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsImmunotherapy, AdoptiveHumansChildReceptors, Chimeric AntigenBlood-Brain BarrierTumor MicroenvironmentAntigens, NeoplasmCytokine Release SyndromeNeurotoxicity SyndromesClinical Trials as Topic

Stichwörter der Autor:innen

T-cellschimeric antigen receptorpediatric brain tumorssolid tumortumor microenvironment

Substanzen

Receptors, Chimeric AntigenAntigens, Neoplasmcell-associated neurotoxicity

Autor:innen und Institutionen

  • Faculty of Medicine and Pharmacy, Mohammed V University in Rabat, 10 170 Rabat, Morocco.
  • Specialties Hospital of Rabat, Ibn Sina University Hospital, 10 170 Rabat, Morocco.
  • Children's hospital of Rabat, Ibn Sina University Hospital, 10 170 Rabat, Morocco.
  • Team of analytical chemistry and bromatology, Faculty of Medicine and Pharmacy, Mohammed V University- Rabat, 10 170 Rabat, Morocco.
  • Ibn Sina University Hospital Center, 10 170 Rabat, Morocco.
  • Team of Formulation and Quality Control of Health Products, Faculty of Medicine and Pharmacy, Mohammed V University- Rabat, 10 170 Rabat, Morocco.

ORCID-Profile: Yasmina Gaoual

Zitieren

APA

Gaoual, Y., Mahyaoui, A., Yachi, L., Bouatia, M., Aliat, Z., & Rahali, Y. (2025). Advancements and challenges in CAR T cell therapy for pediatric brain tumors: A review. Journal of Oncology Pharmacy Practice. https://doi.org/10.1177/10781552251331609

Vancouver

Gaoual Y, Mahyaoui A, Yachi L, Bouatia M, Aliat Z, Rahali Y. Advancements and challenges in CAR T cell therapy for pediatric brain tumors: A review. Journal of Oncology Pharmacy Practice. 2025. doi:10.1177/10781552251331609

BibTeX
@article{Gaoual2025,
  author = {Gaoual, Yasmina and Mahyaoui, Adam and Yachi, Lamyae and Bouatia, Mustapha and Aliat, Zineb and Rahali, Younes},
  title = {Advancements and challenges in CAR T cell therapy for pediatric brain tumors: A review},
  journal = {Journal of Oncology Pharmacy Practice},
  year = {2025},
  doi = {10.1177/10781552251331609}
}
Kostenlos starten →